Correction to: As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?

被引：0
|
作者：
Christian Domingo
Jordi Rello
Ana Sogo
机构：
[1] Corporació Sanitària Parc Taulí,Servei de Pneumologia
[2] Universitat Autònoma de Barcelona (UAB),Departament de Medicina
[3] CIBERES,undefined
[4] Instituto Salud Carlos III and Vall d’Hebron Institute of Research,undefined
来源：
Drugs | 2019年 / 79卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract, fourth to last sentence, which currently reads:
引用
收藏
页码：1739 / 1739
相关论文
共 50 条
  • [41] Stepping down for mild asthma and disadvantages of the 'as-needed' strategy-Perspectives from a developing country
    Nguyen-Ho, Lam
    Nguyen-Nhu, Vinh
    Yoon-Soek, Chang
    Dinh-Xuan, Anh-Tuan
    Le-Thi, Tuyet-Lan
    RESPIROLOGY, 2021, 26 (10) : 917 - 919
  • [42] Rapid and Persistent 6-week Response to ICS/LABA/LAMA in Mild-moderate Asthma
    Sharma, M.
    Kooner, H. K.
    Tcherner, S.
    Mozaffaripour, A.
    Paul, N.
    Yamashita, C.
    Parraga, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study
    Foster, Juliet
    Beasley, Richard
    Braithwaite, Irene
    Harrison, Tim
    Holliday, Mark
    Pavord, Ian
    Reddel, Helen
    BMJ OPEN, 2022, 12 (01):
  • [44] Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective
    FitzGerald, J. Mark
    Arnetorp, Sofie
    Smare, Caitlin
    Gibson, Danny
    Coulton, Karen
    Hounsell, Kirsty
    Sadatsafavi, Mohsen
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study
    Foster, J. M.
    Beasley, R.
    Braithwaite, I
    Harrison, T.
    Holliday, M.
    Pavord, I
    Reddel, H. K.
    RESPIRATORY MEDICINE, 2020, 175
  • [46] As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations
    Bianco, Andrea
    Contoli, Marco
    Di Marco, Fabiano
    Saverio Mennini, Francesco
    Papi, Alberto
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (07): : 873 - 882
  • [47] DOES ADHERENCE TO ICS/LABA THERAPY CHANGE FOLLOWING INITIATION OF BENRALIZUMAB IN THE TREATMENT OF SEVERE ASTHMA AND DOES THIS AFFECT OUTCOME?
    d'Ancona, G.
    Bains, S.
    Bakrania, P.
    Green, L.
    Fernandes, M.
    Roxas, C.
    Thomson, L.
    Osman, L.
    Stewart-Knight, K.
    Dhariwal, J.
    Nanzer, A. M.
    Kavanagh, J.
    Jackson, D. J.
    Kent, B. D.
    THORAX, 2019, 74 : A136 - A136
  • [48] Development of Claims-Based Definitional Algorithms for Moderate and Severe Asthma Exacerbations and Quantification of Exacerbation Rates in Adult Asthmatic Patients Treated with ICS-LABA
    Roberts, M. H.
    Meeraus, W.
    Cheng, W. Y.
    Zhang, S.
    Chang, R.
    Slade, D.
    Duh, M. S.
    Fowler, A.
    Park, S.
    Wu, M.
    Tabberer, M.
    Czira, A.
    Mapel, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [49] As-needed budesonide-formoterol better controlled mild asthma vs terbutaline, but maintenance budesonide was better
    Stanbrook, Matthew B.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (06) : JC31 - JC31
  • [50] Urinary fistulas: What does the evidence say?
    Kim J.-H.
    Smith A.L.
    Raz S.
    Current Bladder Dysfunction Reports, 2008, 3 (4) : 208 - 213
12345